Missing warning prompts Fat Clear recall


Product Recall
Homart Pharmaceuticals announces recall of four batches of its SpringLeaf Fat Clear, due to compliance issues  Labelling issues related to SpringLeaf Fat Clear have prompted a recall of 15 specific batches of the product, the Therapeutic Goods Administration (TGA) reveals.  The regulator noted that the label was missing a required warning about phenylalaine.  “Spirulina, one

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Teals call for extension of prac payments
Next Nominations open for wellbeing warriors